Linezolid Tablet, Film Coated
Product Images NDC 71335-2565

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 71335-2565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Linezolid-image (Linezolid Image)

Linezolid-image (Linezolid Image)
Chemical structure diagram of linezolid, showing its molecular framework with oxygen, nitrogen, fluorine atoms, and a methyl group as part of the structure.*
FDA Label Image

Linezolid-plasma (Linezolid Plasma)

Linezolid-plasma (Linezolid Plasma)
A line graph showing Linezolid plasma concentration (µg/mL) over 12 hours following a 600 mg oral dose every 12 hours. The graph plots concentration decreasing over time with error bars at each point, illustrating drug levels from 0 to 12 hours post-dose.*
FDA Label Image

Label (Lbl713352565)

Label (Lbl713352565)
The label for Linezolid Tablets, 600 mg, film-coated oral tablets. The package contains 20 tablets. It is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Alkem Laboratories Ltd. Storage instructions and child-resistant packaging information are included. The NDC is 71335-2565-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.